| Literature DB >> 35456201 |
Daniel Berman1, Ananth Eleswarapu1, Jonathan Krystal1, Henry Hoang2.
Abstract
Pedicle screw fixation is a technique used to provide rigid fixation in thoracolumbar spine surgery. Safe intraosseous placement of pedicle screws is necessary to provide optimal fixation as well as to avoid damage to adjacent anatomic structures. Despite the wide variety of techniques available, none thus far has been able to fully eliminate the risk of malpositioned screws. Intraoperative 3-dimensional navigation (I3DN) was developed to improve accuracy in the placement of pedicle screws. To our knowledge, no previous studies have investigated whether infection rates are higher with I3DN. A single-institution, retrospective study of patients age > 18 undergoing thoracolumbar fusion and instrumentation was carried out and use of I3DN was recorded. The I3DN group had a significantly greater rate of return to the operating room for culture-positive incision and drainage (17 (4.1%) vs. 1 (0.6%), p = 0.025). In multivariate analysis, the use of I3DM did not reach significance with an OR of 6.49 (0.84-50.02, p = 0.073). Post-operative infections are multifactorial and potential infection risks associated with I3DN need to be weighed against the safety benefits of improved accuracy of pedicle screw positioning.Entities:
Keywords: complications; infections; orthopedics; spine
Year: 2022 PMID: 35456201 PMCID: PMC9025334 DOI: 10.3390/jcm11082108
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Demographic and clinical characteristics by I3DN use in 589 patients.
| I3DN Use N = 417 | No I3DN Use N = 172 | |||
|---|---|---|---|---|
| Age | – | 57.8 ± 12.9 | 57.7 ± 13.3 | 0.96 |
| Gender | Female | 255(61.2) | 115(66.9) | 0.19 |
| Male | 162(38.8) | 57(33.1) | ||
| Return to OR for I&D | No | 400(95.9) | 171(99.4) | 0.025 |
| Yes | 17(4.1) | 1(0.6) | ||
| Return to OR for other reason | No | 366(88.0) | 154(89.5) | 0.59 |
| Yes | 50(12.0) | 18(10.5) | ||
| Surgical time | – | 362.0(279.0–466.0) | 255.5(210.0–349.0) | <0.0001 |
| BMI | – | 29.8(25.3–33.9) | 31.0(26.1–35.0) | 0.1 |
| Use of vancomycin power | No | 167(40.0) | 122(70.9) | <0.0001 |
| Yes | 250(60.0) | 50(29.1) | ||
| Revision status | No | 322(77.2) | 125(72.7) | 0.24 |
| Yes | 95(22.8) | 47(27.3) | ||
| Levels fused | – | 2.0(1.0–4.0) | 2.0(1.0–3.0) | <0.0001 |
| Laminectomy | No | 42(10.1) | 19(11.1) | 0.72 |
| Yes | 375(89.9) | 153(88.9) | ||
| Interbody fusion | No | 254(61.1) | 85(49.4) | 0.009 |
| Yes | 162(38.9) | 87(50.6) | ||
| Diabetes | No | 287(69.0) | 123(71.5) | 0.54 |
| Yes | 129(31.0) | 49(28.5) | ||
| Chronic kidney disease | No | 387(92.8) | 164(95.3) | 0.25 |
| Yes | 30(7.2) | 8(4.7) | ||
| Immunocompromise | No | 385(92.6) | 165(95.9) | 0.13 |
| Yes | 31(7.4) | 7(4.1) | ||
| Hypertension | No | 158(38.0) | 65(37.8) | 0.97 |
| Yes | 258(62.0) | 107(62.2) | ||
| Alcohol/substance abuse | No | 380(91.4) | 149(86.6) | 0.08 |
| Yes | 36(8.6) | 23(13.4) | ||
| Smoking | Never | 226(54.5) | 94(54.6) | 0.55 |
| Former | 120(28.9) | 55(32.0) | ||
| Current | 69(16.6) | 23(13.4) | ||
Specific microorganisms identified based on intra-operative culture.
| O-Arm Use | Microorganism |
|---|---|
| Yes | Klebsiella pneumoniae, finegoldia magna |
| Yes | MRSA |
| Yes | Proteus Mirabilis, Prevotella Bivia |
| No | Proteus Mirabilis |
| Yes | MSSA, Corynebacterium striatum |
| Yes | MRSA |
| Yes | Enterococcus Faecalis, Streptococcus Mitis, Prevotella Bivia |
| Yes | Enterobacter Cloacae |
| Yes | MSSA, Proteus Mirabilis |
| Yes | VRE (Vanco resistant enterococcus) |
| Yes | E Faecalis, E Coli |
| Yes | Pseudomonas |
| Yes | Staph Lugdenesis, Proteus Penneri, Enterococcus |
| Yes | Klebsiella Pneumoniae |
| Yes | Enterobacter Cloacae |
| Yes | MSSA |
| Yes | MSSA |
| Yes | Klebsiella Pneumoniae, Proteus Mirabalis |
Univariable associations of demographics and clinical variables associated with return to OR for I&D.
| Return to OR for I&D | Did not Return to OR for I&D | |||
|---|---|---|---|---|
| Age | – | 62.0 ± 10.5 | 57.6 ± 13.1 | 0.16 |
| Gender | Female | 12(66.7) | 358(62.7) | 0.73 |
| Male | 6(33.3) | 213(37.3) | ||
| Return to OR for other reason | No | 13(72.2) | 507(89.0) | 0.046 |
| Yes | 5(27.8) | 63(11.0) | ||
| Surgical time | – | 476.5(363.0–655.0) | 324.0(250.0–426.0) | 0.0007 |
| BMI | – | 28.2(22.0–31.7) | 30.0(25.9–34.0) | 0.12 |
| Use of vancomycin power | No | 9(50.0) | 280(49.0) | 0.94 |
| Yes | 9(50.0) | 291(51.0) | ||
| Revision status | No | 9(50.0) | 438(76.7)) | 0.02 |
| Yes | 9(50.0) | 133(23.3) | ||
| Levels fused | – | 4.0(2.0–7.0) | 2.0(1.0–3.0) | 0.0008 |
| Laminectomy | No | 4(22.2) | 57(10.0) | 0.11 |
| Yes | 14(77.8) | 514(90.0) | ||
| Interbody fusion | No | 11(64.7) | 328(57.4) | 0.55 |
| Yes | 6(35.3) | 243(42.6) | ||
| Diabetes | No | 11(61.1) | 399(70.0) | 0.42 |
| Yes | 7(38.9) | 171(30.0) | ||
| Chronic kidney disease | No | 18(100) | 533(93.4) | 0.62 |
| Yes | 0(0) | 38(6.6) | ||
| Immunocompromise | No | 18(100) | 532(93.3) | 0.62 |
| Yes | 0(0) | 38(6.7) | ||
| Hypertension | No | 10(55.6) | 213(37.4) | 0.12 |
| Yes | 8(44.4) | 357(62.6) | ||
| Alcohol/substance abuse | No | 18(100) | 511(89.6) | 0.24 |
| Yes | 0(0) | 59(10.4) | ||
| Smoking | Never | 12(66.7) | 308(54.1) | 0.42 |
| Former | 5(27.8) | 170(29.9) | ||
| Current | 1(5.5) | 91(16.0) | ||
Factors associated with return to OR for I&D on multivariable logistic regression.
| Characteristic | Adjusted Odds Ratio (95% CI) | ||
|---|---|---|---|
| I3DN use | Yes | 6.49 (0.84–50.02) | 0.073 |
| No (reference) | 1 | ||
| Revision status | Yes | 2.94 (1.10–7.83) | 0.031 |
| No (reference) | 1 | ||
| Levels fused | – | 1.13 (1.02–1.27) | 0.026 |